Shanghai Haoyuan Chemexpress Co (SHSE:688131) Operating Income: ¥619 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688131 Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
91 GF Score
Price ¥92.26
GF Value ¥68.43
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Shanghai Haoyuan Chemexpress Co Operating Income?

Shanghai Haoyuan Chemexpress Co SHSE:688131 +0.16% 91 Operating Income is ¥619 Mil as of Jun. 2026. GuruFocus rates SHSE:688131 with a GF Score™ of 91/100 and a GF Value™ of ¥68.43 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Shanghai Haoyuan Chemexpress Co's Operating Income for the three months ended in Jun. 2026 was ¥212 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was ¥619 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Shanghai Haoyuan Chemexpress Co's Operating Income for the three months ended in Jun. 2026 was ¥212 Mil. Shanghai Haoyuan Chemexpress Co's Revenue for the three months ended in Jun. 2026 was ¥919 Mil. Therefore, Shanghai Haoyuan Chemexpress Co's Operating Margin % for the quarter that ended in Jun. 2026 was 23.04%.

Warning Sign:

Shanghai Haoyuan Chemexpress Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -9.7%.

Shanghai Haoyuan Chemexpress Co's 5-Year average Growth Rate for Operating Margin % was -9.70% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai Haoyuan Chemexpress Co's annualized ROC % for the quarter that ended in Jun. 2026 was 16.62%. Shanghai Haoyuan Chemexpress Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 17.41%.


Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai Haoyuan Chemexpress Co's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=847.148 * ( 1 - 16.35% )/( (4182.304 + 4343.355)/ 2 )
=708.639302/4262.8295
=16.62 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6489.539 - 660.969 - ( 1646.266 - max(0, 1857.269 - 4008.893+1646.266))
=4182.304

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6699.049 - 737.093 - ( 1618.601 - max(0, 2010.844 - 4178.7+1618.601))
=4343.355

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai Haoyuan Chemexpress Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=526.844/( ( (1492.885 + max(1458.556, 0)) + (1522.11 + max(1580.278, 0)) )/ 2 )
=526.844/( ( 2951.441 + 3102.388 )/ 2 )
=526.844/3026.9145
=17.41 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(684.79 + 1513.635 + 72.307) - (660.969 + 0 + 151.207)
=1458.556

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(799.591 + 1585.205 + 68.854) - (737.093 + 0 + 136.279)
=1580.278

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Shanghai Haoyuan Chemexpress Co's Operating Margin % for the quarter that ended in Jun. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=211.787/919.323
=23.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Shanghai Haoyuan Chemexpress Co Operating Income Related Terms


Shanghai Haoyuan Chemexpress Co Operating Income Historical Data

* Premium members only.

The historical data trend for Shanghai Haoyuan Chemexpress Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haoyuan Chemexpress Co Operating Income Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 249.71 235.77 261.12 433.19 528.73

Shanghai Haoyuan Chemexpress Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.40 164.87 98.33 143.71 211.79
SHSE:688131
91GF Score
Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Haoyuan Chemexpress Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥619 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of ¥619 Mil mean?
Shanghai Haoyuan Chemexpress Co (SHSE:688131) has a Operating Income of ¥619 Mil as of Jun. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors.
Is Shanghai Haoyuan Chemexpress Co's Operating Income too high?
Shanghai Haoyuan Chemexpress Co's current Operating Income is ¥619 Mil. Overall, Shanghai Haoyuan Chemexpress Co has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haoyuan Chemexpress Co's Operating Income compare to ZTS?
Shanghai Haoyuan Chemexpress Co's Operating Income of ¥619 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Drug Manufacturers company?
A good Operating Income depends on the Drug Manufacturers industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. Shanghai Haoyuan Chemexpress Co's current Operating Income is ¥619 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haoyuan Chemexpress Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co (SHSE:688131) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥68.43, compared to a current price of ¥92.26 — trading 34.8% above its estimated fair value. The current Operating Income is ¥619 Mil. Shanghai Haoyuan Chemexpress Co's overall GF Score™ is 91/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Shanghai Haoyuan Chemexpress Co (SHSE:688131), the current Operating Income is ¥619 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued. The current stock price of ¥92.26 is trading 34.8% above its estimated GF Value™ of ¥68.43. GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Significantly Overvalued.

Key valuation signals for SHSE:688131:

  • Operating Income: ¥619 Mil
  • GF Value™: ¥68.43 vs. price of ¥92.26 (34.8% above fair value)
  • GF Score™: 91/100 with 10 warning signs

No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Haoyuan Chemexpress Co Business Description

Address No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
91GF Score

Get the complete analysis for SHSE:688131

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥92.26
Price
¥68.43
GF Value